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Introduction
p53 is a well-known tumor suppressor whose loss of function is 
the most frequent genetic alteration in human cancer. Although 
most of its functional inactivation arises from somatic muta-
tions observed in 50% of human cancers, the p53 pathway is 
also inactivated through indirect mechanisms such as MDM2 
amplification or expression of viral oncoprotein. The p53 func-
tions mainly as a transcriptional factor that directly binds DNA 
through a domain localized in responsive elements.1 Among 
the functions of p53 on hundreds of downstream targets, tran-
scriptional activation of miRs sheds new light on the p53 tumor 
suppressor network,2,3 as tumor-suppressive miRs directly link 
the loss of tumor suppressor function with sustained activation 
of oncogenic signaling pathways. Indeed, it has recently been 
determined that p53 suppresses canonical Wnt and the Snail-
mediated EMT program through transactivation of the miR-34 
family.4-7
The canonical Wnt signaling plays pivotal roles in cell fate 
determination during development and adult tissue homeosta-
sis.8 Mutations of APC or β-catenin resulting in constitutive 
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activation of Wnt signaling, especially in colorectal tumor, are 
implicated in the development of human cancer as well as in 
its progression.9 Intracellular signaling of the canonical Wnt 
pathway largely depends on the regulation of glycogen synthase 
kinase-3 (GSK-3).10 Axin, a key scaffolding protein of GSK-3, 
not only regulates its kinase activity but also shuttles it from the 
cell membrane into the nucleus.11 Although Axin was first identi-
fied as a β-catenin degradation complex with APC in cytoplasm, 
its function is also critical to transduction of the intracellular 
Wnt cascade in the presence of an extracellular Wnt signal. For 
example, the GSK-3 shuttling function of Axin promotes phos-
phorylation of the membranous LRP6 co-receptor, resulting in 
activation of the intracellular canonical Wnt signaling cascade,12 
while the GSK-3 nuclear export function of Axin participates in 
the EMT program of breast as well as colon cancer by stabilizing 
E-cadherin repressor Snail, thus inhibiting serial phosphorylation 
and subsequent proteasomal degradation of Snail.13,14 Whereas 
transcriptional regulation of Axin by TCF/LEF has been clearly 
shown,15,16 post-transcriptional regulation of Axin and nuclear 
GSK-3 trafficking, especially in colorectal cancer, wherein Axin2 
is highly expressed, has been less well studied.
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cancer cells,14 downregulation of endogenous Axin2 promotes 
increased nuclear GSK-3 in conjunction with lowered nuclear 
Snail level (Fig. 1A). Consistent with a well-known function of 
Snail,13,24,25 E-cadherin proximal promoter activity was increased 
by knockdown of Axin2 (Fig. 1B), supporting the notion that 
Axin2 plays an important role regulating Snail-mediated EMT 
programs via a nuclear GSK-3 shuttling function in colorectal 
cancer cells.14,26
p53/miR-34a axis suppresses Axin2 expression in human 
colon cancer cells. Recently, we have reported that p53 directly 
suppresses a set of GSK-3-related canonical Wnt genes including 
Wnt1, Wnt3, LRP6, β-catenin, LEF1 and Snail1.5,6 As Axin2 is a 
key regulator of GSK-3 in canonical Wnt signaling and the Snail-
mediated EMT program, we examined whether Axin2 is also 
regulated by the p53/miR-34 axis in colorectal cancer cells. In a 
panel of characterized colorectal cancer cell lines, HCT116 and 
RKO cells having wild type (wt) p53 function showed lowered 
expression of Axin2 protein level, while SW480 and SW620 cells 
having mutant p53 protein exhibited increased Axin2 expression 
(Fig. 2A). Notably, isogenic knockout of p53 in HCT116 cells 
showed increased Axin2 protein level compared with wild type 
(wt) cells, suggesting that the p53 tumor suppressor function 
regulates Axin2 expression in colorectal cancer cells. Because the 
miR-34 level is mainly regulated via the transcriptional func-
tion of p53,2,3,27,28 we next examined the quantitative expression 
of miR-34 and Axin2 transcripts. In these cells, Axin2 mRNA 
expressions were consistent with protein expression level and 
inversely correlated with pri-miR-34a as well as mature miR-
34a expression (Fig. 2B). As with protein abundance, Axin2 
transcript level was significantly increased, whereas miR-34 was 
downregulated in p53-null isogenic HCT116 cells compared 
Although identification of miR targets relies mainly on 
sequences at the 5' end of the miR, known as the “seed match,”17,18 
we have reported miR interaction sites not only on the 3' UTR but 
also on the 5' UTR.19 In this molecular model, a miR can interact 
with both end regions of an mRNA through combinatory inter-
actions of the 3'- and 5'-end of one miR with the 5'-UTR and 
3'-UTR of the target mRNA, respectively.19 In such reciprocal 
miR-mRNA interactions, non-coding UTRs of mRNA can con-
versely modulate endogenous miRs, as in the “sponge” effect,20 
and non-coding regions of mRNA transcripts can regulate other 
mRNA transcripts (so called “competing endogenous RNA, 
ceRNA”) through the competition and titration of endogenous 
miRs.4,21-23 Following on recent reports of the functional and 
clinical relevance of the p53/miR-34 axis and Wnt on EMT and 
cancer progression,5-7 we show here that p53 and miR-34 directly 
control Axin2 post-transcriptionally in colorectal cancer cells, 
thereby regulating Axin2-dependent nuclear GSK-3 levels. We 
also demonstrate that expression of the non-coding 5' UTR as 
well as of the 3' UTR of Axin2 leads to depletion of endogenous 
miR-34 together with increased endogenous Axin2 expression, 
and the non-coding UTR of Axin2 transcripts and miR-34 par-
ticipate in the genome wide RNA-RNA network of Wnt signal-
ing in colorectal cancer.
Results
Axin2 regulates nuclear GSK-3 localization and Snail-
mediated E-cadherin promoter activity in colorectal can-
cer cells. We chose several colorectal cancer cells having high 
levels of Axin2 to examine its function on nuclear GSK-3 and 
its direct substrate Snail level. Similar to the case in breast 
Figure 1. Nuclear GSK-3 level regulated by Axin2 expression in colorectal cancer cell lines. (A) Immunoblot analysis of Axin2 in whole-cell lysate, 
GSK-3 and Snail in nuclear fraction after siRNA-mediated knockdown of Axin2 in HCt116-p53−/−, SW480 and SW620 cells. tubulin and HDAC were used 
as the loading control of whole-cell lysate and nuclear fraction, respectively. (B) e-cadherin proximal promoter activities of firefly luciferase reporter 
constructs were determined in HCt116-p53−/−, SW480 and SW620 cells. Increases in e-cadherin promoter activity were observed with siRNAs against 
Axin2 compared with scrambled siRNA control. Activity of the e-cadherin proximal promoter constructs was normalized to that of a cotransfected SV-
40-driven Renilla luciferase construct. Results are expressed as the mean ± SD of triplicate.
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the 3'-end of miR-34.19 Potential target sites of miR-34 on the 
Axin2 3' UTR as well as on the 5' UTR were predicted by the 
miBridge algorithm (Table S1), as shown in Figure 3A. While 
miR-34b/c as well as miR-34a is transcribed by p53, we focused 
on miR-34a function, since it is most abundant in cells.2,3,28 
To examine the functionality of miR-34 on Axin2 UTRs, we 
performed the reporter assay of Axin2 UTR with miR-34a in 
p53-null or p53 mutant colon cancer cells. The Axin2 reporter 
activities of the 5' UTR as well as of the 3' UTR were down-
regulated by exogenous miR-34a in these colorectal cancer cells 
(Fig. 3B), and the putative overlapping target sites on the 5' UTR 
were functional in HCT116 cells (Fig. 3C).19 Consistent with 
reporter activities, endogenous Axin2 expression level was signifi-
cantly suppressed by miR-34, whereas nuclear GSK-3 increased 
with wt HCT116. To further assess the functionality of p53 on 
Axin2 expression, we administered the genotoxic agent adriamy-
cin to induce p53 and then analyzed the relationship between the 
p53/miR-34a axis and Axin2 in these cells. As expected, Axin2 
protein abundance in wt HCT116 and RKO cells was signifi-
cantly suppressed by induction of wt p53 but was unchanged 
in p53-null HCT116 cells or p53 mutant colorectal cancer cells 
(Fig. 2C). An inverse correlation between Axin2 protein and miR-
34 transcript abundance was identified by induction of wt p53 
(Fig. 2D), supporting that p53 and miR-34 negatively regulate 
Axin2 in colorectal cancer cells.
miR-34 target sites on Axin2 UTRs. Compared with that 
of lower vertebrates, human Axin2 mRNA possesses a relatively 
longer 5' UTR (NM_004655.3), which potentially interacts with 
Figure 2. p53 and miR-34 inversely correlated with Axin2 expression. (A) endogenous Axin2 level was determined by immunoblot analysis in a panel 
of colorectal cancer cell lines according to the p53 functional status. tubulin was used as the loading control. (B) the transcript levels of Axin2 and 
pri-miR-34a (upper panel) and mature miR-34a (lower panel) were determined by quantitative Rt-pCR analysis in a panel of colorectal cancer cells. 
Results are expressed as the mean ± SD of triplicate experiment. (C) Immunoblot analysis of endogenous p53 and Axin2 protein levels after treatment 
of 0.1 mg/ml adriamycin (ADR) for 8 h in colorectal cancer cells. (D) Quantitative Rt-pCR analysis of pri-miR-34a transcript levels after treatment of ADR. 
Results are expressed as the mean ± SD of triplicate experiment.
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GSK-3 levels through direct targeting of Axin2 transcripts in 
colorectal cancer cells.
p53 and endogenous miR-34 regulate nuclear GSK-3 levels 
via Axin2 UTR in HCT116 cells. Given the mature miR-34a 
level and Axin UTR activity in HCT116 cells and isogenic p53−/− 
HCT116 cells, we next compared UTR reporter activities on 
(Fig. 3D) in these cells. For clear evidence of miR-34 targeting 
of Axin2 transcripts, we chose and analyzed a data set of Dicer−/− 
colorectal cancer cells that would allow us to observe effects of 
such direct targeting.2 Indeed, Axin2 transcript abundances were 
decreased by the miR-34 family in Dicer−/− colorectal cancer cells 
(Fig. 3E), supporting that p53 and miR-34 modulate nuclear 
Figure 3. miR-34 directly targets Axin2 UtRs. (A) predicted Axin2 target sites (NM_004655.3) of miR-34a-5p, miR-34b-5p and miR-34c-5p are indicated 
by the arrows on the 5' UtR and 3' UtR. (B) Inhibition of 5' and 3' UtR reporter activities of Axin2 by miR-34a. Relative luciferase activity by miR-34 in 
comparison to the non-UtR control luciferase reporter is shown; the error bar represents the SD of triplicate experiment. Relative reporter activity 
= (ULuc/URenilla)/(CLuc/CRenilla); U, UtR vector; C, luciferase vector control; Luc, raw firefly luciferase activity; Renilla, internal transfection control renilla 
activity. (C) effect of mutation on the 5' UtR. the luciferase reporter having 3' UtR of Axin with wild type 5' UtR or mutant 5' UtR was transfected into 
the HCt116 cells and the relative 5' UtR mutant reporter activity compared with wild type UtR after transduction with a negative control oligo (N/C) 
or miR-34a (*p < 0.01 compared with control, t-test). (D) Immunoblot analysis of Axin2 and nuclear GSK-3 levels after transfection of control (−) or 
miR-34a in p53-null or p53-mutant colorectal cancer cells. (E) An unsupervised hierarchical clustering based on Axin2 transcript expression profiles in 
Dicer−/− HCt116 and DLD1 colorectal cancer cells with the miR-34 transduction. In the heatmap, red denotes higher relative expression, whereas green 
indicates lower relative expression, with degree of color saturation reflecting the magnitude of the log expression signal.
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samples suggests that miR-34 acts as a trans modulator in co-
expression of the target genes.
Discussion
The tumor suppressor function of p53 in various oncogenic 
signaling events such as increased β-catenin expression result-
ing from loss of p53 function has long been observed.1,30 Axin 
and GSK-3 dynamics have been shown to be regulated by p53, 
although the mechanistic links between p53 and Axin were not 
identified.31 Recently, the miR-34 family, which is directly tran-
scribed by the p53 tumor suppressor, has emerged as a mechanis-
tic link between the p53 and canonical Wnt signaling and EMT 
program.4-6,32 In this process, a set of GSK-3-related Wnt genes, 
including EMT inducer Snail, are directly targeted by p53 and 
miR-34, demonstrating that the p53/miR-34 axis endogenously 
suppresses canonical Wnt signaling and the Snail-mediated EMT 
program.4-6 In this study, we report that the p53 tumor suppressor 
axis also modulates nuclear GSK-3 level by targeting the Axin2 
UTRs in colorectal cancer. Taken together with the well-known 
post-translational and post-transcriptional regulation of Wnt and 
the EMT program by the p53/miR-34 axis,4-6 these observations 
demonstrate the close connection between the tumor suppressor 
function and oncogenic signaling in human cancer.
GSK-3 is a widely expressed and multifunctional Ser/Thr 
kinase involved in a broad range of biological processes, from 
glycogen metabolism to transcriptional program and cell cycle 
regulation.33,34 GSK-3 is constitutively active under resting con-
ditions and acts as a core regulator in pathways implicated in 
diseases such as Alzheimer, diabetes, bipolar disorder and cancer. 
In these distinct biological contexts, scaffolding proteins insulat-
ing the kinase activity confer signaling selectivity and substrate 
specificity.33,34 Together with its kinase activity, GSK-3's subcel-
lular localization and sequestration by a number of binding part-
ners are key elements in cellular signaling, especially with regard 
to β-catenin and Snail activity.35 In canonical Wnt signaling, a 
membrane-localized form of GSK-3 recruited with Axin is essen-
tial to LRP6 phosphoryation and subsquent activation for signal 
transduction.12 In this process, membranous GSK-3, unlike cyto-
solic GSK-3, stimulates canonical Wnt signaling. Further, Axin 
promotes EMT by acting as a shuttling chaperone for nuclear 
GSK-3, which is responsible for controlling Snail protein activ-
ity through post-translational modification.14,26,36 Interestingly, 
nuclear GSK-3 is highly active compared with its major cytosolic 
fraction, its kinase activity in colon cancer cells being enhanced 
by silencing of Axin2,26,37 indicating that Axin functions as a key 
regulator of GSK-3 in Wnt signal transduction not only in terms 
of kinase activity, but also with respect to intracellular compart-
mentalization. Considering the large amount of GSK-3 substrate 
in nuclear transcription factors such as Snail, the p53/miR-34 
axis regulating nuclear GSK level comprises a wide range of gene 
functions beyond β-catenin-mediated canonical Wnt signaling 
and the Snail-mediated EMT program.
A key component in canonical Wnt signaling, Axin serves as a 
multimeric scaffold for a regulatory complex including β-catenin, 
GSK-3, APC (adenomatous polyposis coli), CK1, Dishevelled, 
these cells to further assess the functional effect of p53 on Axin2 
expression and nuclear GSK-3β level. Axin2 UTR reporter activ-
ities and endogenous Axin2 protein level consistently increased 
in p53-null HCT116 cells, while loss of wt p53 decreased nuclear 
GSK-3 (Fig. 4A). Separately, transduction of wt p53 into p53-
null HCT116 cells reversed the consequences of p53 knockout 
in terms of UTR activities, mature miR-34, Axin2 expression 
and nuclear GSK-3 expression level (Fig. 4B). Functional deple-
tion in wt HCT116 cells of endogenous miR-34a, the most 
abundant member of the miR-34 family, by complementary 
RNA showed effects similar to p53-loss on reporter activities and 
nuclear GSK-3 (Fig. 4C), suggesting that endogenous miR-34 in 
HCT116 is functional for p53-mediated Axin2 repression.
miR-34 is inversely correlated with Axin2 in colorectal 
cancer samples. Loss of wt-p53 function tends to occur prior to 
invasive colorectal carcinoma.29 To confirm the loss of miR-34 
accompanying increased Axin2 transcripts, we obtained 10 cases 
of colon cancer tissues paired with adjacent normal mucosa and 
measured the mRNA expression of Axin2 and pri-miR-34a using 
quantitative real-time PCR. Compared with paired normal tis-
sues, miR-34a mRNA levels were significantly lower in human 
colon cancer samples, whereas Axin2 expression was higher 
(Fig. 5), supporting that the miR-34 and Axin2 transcripts were 
inversely correlated in colorectal cancer progression.
Non-coding Axin2 UTR depletes endogenous miR-34 and 
suppresses Axin2 function. Because miRs mediate networks of 
RNA-RNA interaction,22,23 non-coding Axin2 UTR functions as 
a cis regulatory element that increases expression of endogenous 
Axin2 transcripts and protein expression.4 To determine the role 
of the non-coding Axin2 UTR in RNA interactions, we overex-
pressed luciferase expression construct having the 3' and/or 5' 
UTR of Axin2 in HCT116 cells and in Dicer mutant HCT116 
cells (HCT116 DicerEX5). The expression of the non-coding UTR 
increased the abundance of Axin2 protein with decreased nuclear 
GSK-3 and Snail expression, whereas the effects were minimal 
in Dicer mutant cells (Fig. 6A). Indeed, the endogenous mature 
miR-34a was depleted by expression on the non-coding UTR of 
Axin2 via the miR-sponge effect in HCT116 cells, whereas it was 
undetected in Dicer mutant cells (Fig. 6B), revealing that the 
non-coding UTR can regulate endogenous Axin2 via titration of 
miR-34. Interestingly, expression of both the 5' UTR and 3' UTR 
affects the depletion of miR-34 and functionality of endogenous 
Axin2. Taking into account the Axin2 transcript function as a 
ceRNA (competing endogenous RNA), our previous observa-
tions predict that transcripts targeted by miR-34 are co-regulated 
through RNA-RNA interactions.4,5 To understand the genome-
wide context of such interactions, we chose a publicly available 
colorectal cancer data set of 177 patients from the Moffitt can-
cer center (GSE17536) and analyzed the co-expression of RNA 
transcripts of miR-34 target genes and Axin2. Significantly, 
LEF1, WNT3 and LRP6 transcripts revealed differential expres-
sion when the samples were subcategorized according to Axin2 
expression levels (Fig. 6C). Calculating the Pearson correlation 
coefficients between each transcript and Axin2 expression lev-
els, we found these transcripts to be significantly correlated with 
Axin2 in each sample (Fig. 6D). The ceRNA function in these 
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development,42 suggesting that Axin function is mainly regulated 
by transcriptional activation or post-transcriptional regulation of 
Axin2. β-catenin directly induces transcription of Axin2 through 
TCF/LEF consensus binding sites on its promoter,15,16 and Axin2 
MEKK4 and protein phosphatase 2.38-41 While Axin1 is 
expressed ubiquitously during embryogenesis, Axin2 expression 
is restricted to specific tissues. Interestingly, Axin1 and Axin2 
proteins are functionally equivalent in mouse embryogenesis and 
Figure 4. p53 and endogenous miR-34 are functional for Axin2 suppression and nuclear GSK 3 levels. (A) UtR reporter assay and immunoblot analysis 
in wt vs. p53-null HCt116 cells. UtR reporter activities of Axin2 5' UtR or/and 3' UtR constructs were compared with wt p53 and p53−/− isogenic HCt116 
cells (left). the UtR reporter activities were significantly increased by loss of p53 function (*p < 0.01 compared with control, t-test). Immunoblot 
analysis of Axin2 and nuclear GKS3 levels in wt vs. p53-null HCt116 cells. tubulin and HDCA1 are used as the loading control of whole-cell lysates and 
nuclear fraction, respectively. (B) UtR reporter (left), mature miR-34a (middle) and immunoblot analyses (right) after adenoviral transduction with a 
control (ad-GFp) or wt p53 (ad-p53) expression vector in p53-null HCt116 cells (*p < 0.01 compared with control, t-test). the endogenous Axin2 and 
nuclear GSK-3 levels were determined after transduction of adenovirus. (C) Inhibition of endogenous miR-34a increased activity of Axin2 UtR reporter 
in wt HCt116 cells (left, *p < 0.05 compared with control, t-test). Immunoblot analysis of Axin2 and nuclear GSK-3 level after transduction of negative 
control oligo (−) or anti-miR-34a (+) in HCt116 cells.
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reporter constructs pGL3-Ecad(-108)-wt-Luc and pGL3-
Ecad(-108)-3× Mut-Luc were used as described previously.13,14 
The activity of E-cadherin reporter constructs was normalized 
to the activity of the co-transfected SV40-renilla luciferase con-
struct (2 ng, Promega). Cells were lysed at 48 h after transfec-
tion, and the relative ratio of renilla luciferase to firefly luciferase 
activity was measured in a dual luciferase assay from triplicate 
experiment (Promega).
Axin2 UTR reporter and miR experiments. The luciferase 
reporter of pcDNA3.1-Hyg(+), a mammalian expression vec-
tor, was used as described previously.5,19 Briefly, the 3' UTR 
of Axin2 (NM_004655.3; +1 ~+1,059) was amplified from 
genomic DNA of MCF-7 cells and cloned into the BamH1 and 
NotI sites downstream of luciferase. The recent version of miR-
34 family annotations and sequences were obtained from miR-
Base (www.mirbase.org). The wild type and mutant synthetic 
oligonucleotide containing 59-bp 5' UTR sequences putatively 
targeted by miR-34a (wt; 5'-GCC CGG GGG AGT CGG 
CTG GAG CCG GCT GCG CTT TGA; +141 ~+179, putative 
overlapped miR-34 target region underlined, mut; GCC CGG 
GGG AGg gat agT GGt cgG GCT GCG CTT TGA, muta-
tion of predicted target sites lowercase letters) was inserted into 
NheI and BamH1 sites upstream of luciferase as described pre-
viously (GR 2009). The UTR reporter assays were performed 
as described previously.5,6 Briefly, the cells were co-transfected 
with each of the Axin2 UTR reporter constructs (5 ng) and syn-
thetic miRNA (Ambion) as indicated. As a transfection control, 
1 ng of SV40-promoter driven Renilla construct (Promega) was 
co-transfected with reporter vectors. For functional analysis of 
expression level is elevated in colorectal cancer as a result 
of β-catenin/TCF activation. In this study, we show that 
p53 suppresses Axin2 expression in colorectal cancer cells, 
and that loss of p53 function induces sustained activation 
of Axin2 via loss of transcriptional regulation of the miR-
34 family. As TCF/LEF transcriptional activity is directly 
suppressed by the p53/miR-34 axis,5 this study suggests 
that p53 governs Wnt genes by direct targeting of indi-
vidual genes in tandem with post-translational regulation 
of the signaling cascade.4
miRs are small non-coding RNAs which post-tran-
scriptionally regulate mRNA stability and protein transla-
tion. Although 7–8 nt seed-matched sites on the 5'-ends 
of miRs are known to preferentially bind to the 3'-UTRs 
of mRNAs,18,43 some genes of higher mammals have a 5' 
UTR site that interacts with the 3'-end of the miR, allow-
ing combinatory interactions between a single miR and 
both ends of the mRNA. For example, the 3' end of an 
individual miR-34 can directly target the 5' UTR of Axin2 
transcripts, leading to mRNA deadenylation and inhibit-
ing protein translation in a cap-dependent fashion.19,44 In 
this study, we show that overexpression of the Axin2 5' 
UTR as well as of the 3' UTR is sufficient to deplete endog-
enous miR-34 and to induce Axin2 protein expression as 
a cis regulator. We also showed co-expression of Axin2 
and other miR-34 target genes in colorectal cancer sam-
ples, consistent with Axin2 functioning as a miR-sponge 
competing with other endogenous RNAs through non-coding 
UTRs,22,23 suggesting that increased expression of the endog-
enous Axin2 transcript in colorectal cancer comprises a range 
of RNA-RNA interactions beyond the protein coding function 
of the transcripts. Conversely, endogenous miR-34 dynamically 
reduces peaks in canonical Wnt genes to maintain balanced sig-
naling by means of dynamic range compression,4 whereas endog-
enous depletion of miR-34 due to loss of p53 function during 
later-stage colorectal adenoma contributes to sustained activa-
tion of the canonical Wnt signaling RNA network and the EMT 
program.
Materials and Methods
Cell lines and expression vectors. Colorectal cancer cells SW480, 
SW620 and RKO cell lines were obtained from ATCC and main-
tained according to the manufacturer’s instructions. HCT116, 
Dicer mutant EX5 cells and p53−/− isogenic cells were kindly pro-
vided from Dr Vogelstein’s lab as described previously.6,45 The 
functional status of p53 in colorectal cancer cell lines was con-
firmed through the TP53 database (www-p53.iarc.fr).
Constructs and viral transduction. Adenovirus expressing 
GFP (ad-GFP, #1060) and GFP-p53 (ad-GFP-p53, #1260) were 
purchased from Vector Biolabs. p53−/− HCT116 was transduced 
with adenoviral vectors by directly applying the diluted viruses to 
the culture medium at 100 multiplicity of infections as described 
previously.5 The transduction efficiency was determined by direct 
visualization using fluorescent microscopy of GFP-expressing 
cells. Wild type and 3× E-box mutated E-cadherin proximal 
Figure 5. expression of Axin2 in matched human colon cancer samples. Quan-
titative real-time pCR analysis of miR-34a and Axin2 was performed on DNA 
isolated from either colon cancer or paired counterpart normal tissues; results 
are expressed as the expression levels in cancer tissue relative to normal tissue. 
experiments were performed in triplicate and the log expression values in all 
panels normalized to the levels of GApDH.
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Microarray data analysis. Publicly available gene expression 
data sets of Dicer−/− colorectal cancer cells (GSE7864) and of 177 
patients from the Moffitt cancer center (GSE17536) were down-
loaded and processed as described previously.4,5 In GSE7864, the 
transcript expression levels of AXIN2 (10023806666 AXIN2, 
10025909737 AXIN2) were compared according to miR-34 
transduction. The transcript levels of LEF1 (221558_s_at), LRP6 
(34697_at) and WNT3 (229103_at) were compared according 
to high and low subsets of AXIN2 (222696_at). The subsets 
were determined based on the median expression level of Axin2 
in the Moffitt cohort and their p-values obtained from student 
miRNA precursor, 20 nM of miR-34 (Ambion, PM11030) and 
negative control (Ambion, AM17110) were transduced with lipo-
fectamine 2000 (Invitrogen). For functional inhibition of endog-
enous miRNA, anti-miR-34a inhibitor (Ambion, AM11030) and 
negative control (Ambion, AM17110) were used. Cells were lysed 
at 48 h after transfection and the relative ratio of Renilla to firefly 
luciferase was measured with dual luciferase assay (Promega). For 
ceRNA experiment, the Axin2 UTR reporter constructs were 
transiently transfected into the wt-HCT116 or isogenic Dicer 
mutant EX5 HCT116 cells, and subjected for immunoblot and 
quantitative RT-PCR assay as described previously.5
Figure 6. RNA-RNA interaction of non-coding Axin2 UtRs in colorectal cancer cells and clinical data set. (A) Immunoblot analysis of Axin2, nuclear 
GSK-3 and Snail levels was performed following transfection of the firefly luciferase expression vectors without UtR (mock) or having UtR in HCt116 
(left panels) and DicereX5 (right panels) cells. (B) the relative expression levels of mature miR-34a were determined by taqMan quantitative Rt-pCR after 
transfection in HCt116 cells of the firefly luciferase expression vectors without UtR (mock) or having UtR (*p < 0.01 compared with control, t-test).  
(C) Comparison of miR-34 target genes of LeF1, LRp6 and WNt3 transcript levels between two subsets of AXIN2 in 177 cases of colorectal cancer patient 
samples (GSe17536). (D) pearson correlation scatter plots of AXIN2 ceRNA transcripts in GSe17536. the p values for correlation coefficients of LeF1, LRp6 
and WNt3 were 4.79e-05, 2.97e-08 and 1.97e-02, respectively. See the “Materials and Methods” section for data processing and statistical analysis.
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400 μl of hypotonic buffer (10 mM HEPES, pH 7.9; 10 mM 
KCl; 1 mM DTT with protease inhibitors) on ice for 5 min. 
The cell membrane was ruptured by adding 10% NP-40 solu-
tion to a final concentration of 0.6%, then vigorously vortexed 
for 10 sec followed by high-speed centrifuge (12,000 rpm of 
microcentrifuge) for 30 sec. After removal of supernatant cyto-
solic fraction, the nuclear pellets were washed with ice-cold PBS 
twice and subjected to nuclear protein extraction with 40 μl of 
hypertonic buffer (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1 mM 
DTT with protease inhibitor cocktail) for 15 min on ice followed 
by maximum speed microcentrifuge to remove insoluble pre-
cipitate. Antibodies against Axin2 (Cell Signaling Technology), 
Snail (Cell Signaling Technology), GSK-3β (BD bioscience), 
p53 (DO-1, Santa Cruz), HDAC1 (Santa Cruz) and Tubulin 
(Labfrontier) were commercially available.
Statistical analysis. Statistical significance of reporter assays 
was determined by the Student’s t-test.
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t-test. The scatter plots were obtained using the Correl function 
for Pearson correlation between LEF1 or LRP6 or WNT3 and 
AXIN2 transcripts. The p-values of correlation coefficients were 
obtained from 10,000 permutations.
Quantitative real-time PCR analysis and clinical samples 
of colorectal cancer tissue. The relative expression levels of 
Axin2 and pri-miR-34a transcript were determined by real 
time quantitative PCR analysis as described previously.5 Briefly, 
total RNA of the cells was isolated with Trizol (Invitrogen) and 
cDNA was synthesized using random hexamer reverse transcrip-
tion primer (Intron). Axin2 and miR-34a transcripts levels were 
detected using the 7300 Real-Time PCR System and SYBR 
Green (Applied Biosystems) and both normalized to the levels of 
GAPDH; the relative log2 expression levels in cancer tissue com-
pared with paired normal tissue were then calculated. Primers 
that amplify human Axin2, pri-miR-34a or GAPDH were 
designed using Primer3 software, the oligonucleotide sequences 
of the primers having been described previously.5 For quantita-
tive analysis of mature miR-34a levels, human TaqMan miRNA 
assay kits (Applied Biosystems, assay ID 000426 for miR-34a 
and ID001973 for U6 snRNA) were used for reverse transcrip-
tion with specific primers and qPCR was performed with corre-
sponding probes (n = 3). Ten cases of colorectal adenocarcinoma 
patient tissues paired with normal mucosa (IRB exempted) were 
obtained from Severance Hospital Gene Bank, total RNA being 
isolated with Trizol.
Western blot analysis. The protein levels of p53 and Axin2 
were detected by western blot analysis of whole-cell lysate with 
Triton X-100 as described previously.13 The expression levels of 
endogenous GSK-3 and Snail were detected from nuclear fraction 
of protein lysates with hypotonic buffer as described previously.14 
Briefly, the cells (0.5 × 106) were collected in microcentrifuge 
tubes after trypsinization and the PBS washed cells treated with 
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